Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
The Role of Nutraceuticals in Statin Intolerant PatientsJournal of the American College of Cardiology, 2018-07, Vol.72 (1), p.96-118 [Peer Reviewed Journal]2018 American College of Cardiology Foundation ;Copyright © 2018 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Jul 3, 2018 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2018.04.040 ;PMID: 29957236Full text available |
|
2 |
Material Type: Article
|
Lipid-Reduction Variability and Antidrug-Antibody Formation with BococizumabThe New England journal of medicine, 2017-04, Vol.376 (16), p.1517-1526 [Peer Reviewed Journal]Copyright © 2017 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1614062 ;PMID: 28304227Full text available |
|
3 |
Material Type: Article
|
Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)Pharmaceuticals (Basel, Switzerland), 2023-04, Vol.16 (4), p.577 [Peer Reviewed Journal]COPYRIGHT 2023 MDPI AG ;2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 by the authors. 2023 ;ISSN: 1424-8247 ;EISSN: 1424-8247 ;DOI: 10.3390/ph16040577 ;PMID: 37111334Full text available |
|
4 |
Material Type: Article
|
Genetics of Cardiovascular Disease: How Far Are We from Personalized CVD Risk Prediction and Management?International journal of molecular sciences, 2021-04, Vol.22 (8), p.4182 [Peer Reviewed Journal]2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 1422-0067 ;ISSN: 1661-6596 ;EISSN: 1422-0067 ;DOI: 10.3390/ijms22084182 ;PMID: 33920733Full text available |
|
5 |
Material Type: Article
|
Genetics of Familial Hypercholesterolemia: New InsightsFrontiers in genetics, 2020-10, Vol.11, p.574474-574474 [Peer Reviewed Journal]Copyright © 2020 Vrablik, Tichý, Freiberger, Blaha, Satny and Hubacek. 2020 Vrablik, Tichý, Freiberger, Blaha, Satny and Hubacek ;ISSN: 1664-8021 ;EISSN: 1664-8021 ;DOI: 10.3389/fgene.2020.574474 ;PMID: 33133164Full text available |
|
6 |
Material Type: Article
|
Familial Hypercholesterolemia: Real-World Data of 1236 Patients Attending a Czech Lipid Clinic. A Retrospective Analysis of Experience in More than 50 years. Part I: Genetics and Biochemical ParametersFrontiers in genetics, 2022-02, Vol.13, p.849008-849008 [Peer Reviewed Journal]Copyright © 2022 Todorovova, Altschmiedova, Vrablik and Ceska. ;Copyright © 2022 Todorovova, Altschmiedova, Vrablik and Ceska. 2022 Todorovova, Altschmiedova, Vrablik and Ceska ;ISSN: 1664-8021 ;EISSN: 1664-8021 ;DOI: 10.3389/fgene.2022.849008 ;PMID: 35295947Full text available |
|
7 |
Material Type: Article
|
Familial Hypercholesterolemia: Real-World Data of 1236 Patients Attending a Czech Lipid Clinic. A Retrospective Analysis of Experience in More than 50 years. Part II. Clinical CharacteristicsFrontiers in genetics, 2022-03, Vol.13, p.849267-849267 [Peer Reviewed Journal]Copyright © 2022 Altschmiedova, Todorovova, Vrablik, and Ceska. ;Copyright © 2022 Altschmiedova, Todorovova, Vrablik, and Ceska. 2022 Altschmiedova, Todorovova, Vrablik, and Ceska ;ISSN: 1664-8021 ;EISSN: 1664-8021 ;DOI: 10.3389/fgene.2022.849267 ;PMID: 35368707Full text available |
|
8 |
Material Type: Article
|
Homeostasis Model Assessment for Insulin Resistance Mediates the Positive Association of Triglycerides with DiabetesDiagnostics (Basel), 2024-04, Vol.14 (7), p.733 [Peer Reviewed Journal]COPYRIGHT 2024 MDPI AG ;2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2075-4418 ;EISSN: 2075-4418 ;DOI: 10.3390/diagnostics14070733 ;PMID: 38611646Full text available |
|
9 |
Material Type: Article
|
Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)Pharmacological research, 2023-03, Vol.189, p.106679 [Peer Reviewed Journal]EISSN: 1096-1186 ;DOI: 10.1016/j.phrs.2023.106679Digital Resources/Online E-Resources |
|
10 |
Material Type: Article
|
Reduced Introgression of Sex Chromosome Markers in the Mexican Howler Monkey (Alouatta palliata × A. pigra) Hybrid ZoneInternational journal of primatology, 2019-02, Vol.40 (1), p.114-131 [Peer Reviewed Journal]The Author(s) 2018 ;International Journal of Primatology is a copyright of Springer, (2018). All Rights Reserved. © 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0164-0291 ;EISSN: 1573-8604 ;DOI: 10.1007/s10764-018-0056-4 ;PMID: 30880850Full text available |
|
11 |
Material Type: Article
|
A Phase 3 Randomized Controlled Trial to Evaluate Efficacy and Safety of New-Formulation Zenon (Rosuvastatin/Ezetimibe Fixed-Dose Combination) in Primary Hypercholesterolemia Inadequately Controlled by StatinsJournal of cardiovascular pharmacology and therapeutics, 2022-01, Vol.27, p.10742484221138284The Author(s) 2022 ;ISSN: 1074-2484 ;EISSN: 1940-4034 ;DOI: 10.1177/10742484221138284 ;PMID: 36420979Full text available |
|
12 |
Material Type: Article
|
Rare variants in known and novel candidate genes predisposing to statin-associated myopathyPharmacogenomics, 2016-08, Vol.17 (13), p.1405-1414 [Peer Reviewed Journal]Future Medicine Ltd ;Copyright Future Medicine Ltd Aug 2016 ;ISSN: 1462-2416 ;EISSN: 1744-8042 ;DOI: 10.2217/pgs-2016-0071 ;PMID: 27296017Full text available |
|
13 |
Material Type: Article
|
Oral anticoagulant treatment in rheumatoid arthritis patients with atrial fibrillation results of an international auditInternational journal of cardiology. Heart & vasculature, 2022-10, Vol.42, p.101117-101117, Article 101117 [Peer Reviewed Journal]2022 The Authors ;2022 The Authors. ;2022 The Authors. Published by Elsevier B.V. 2022 ;ISSN: 2352-9067 ;EISSN: 2352-9067 ;DOI: 10.1016/j.ijcha.2022.101117 ;PMID: 36118256Full text available |
|
14 |
Material Type: Article
|
Cardiovascular Risk in Myositis Patients Compared to the General Population: Preliminary Data From a Single-Center Cross-Sectional StudyFrontiers in medicine, 2022-05, Vol.9, p.861419-861419 [Peer Reviewed Journal]Copyright © 2022 Oreska, Storkanova, Kudlicka, Tuka, Mikes, Krupickova, Satny, Chytilova, Kvasnicka, Spiritovic, Hermankova, Cesak, Rybar, Pavelka, Senolt, Mann, Vencovsky, Vrablik and Tomcik. ;Copyright © 2022 Oreska, Storkanova, Kudlicka, Tuka, Mikes, Krupickova, Satny, Chytilova, Kvasnicka, Spiritovic, Hermankova, Cesak, Rybar, Pavelka, Senolt, Mann, Vencovsky, Vrablik and Tomcik. 2022 Oreska, Storkanova, Kudlicka, Tuka, Mikes, Krupickova, Satny, Chytilova, Kvasnicka, Spiritovic, Hermankova, Cesak, Rybar, Pavelka, Senolt, Mann, Vencovsky, Vrablik and Tomcik ;ISSN: 2296-858X ;EISSN: 2296-858X ;DOI: 10.3389/fmed.2022.861419 ;PMID: 35602501Full text available |
|
15 |
Material Type: Article
|
Regional differences in physicians' behavior and factors influencing the intensity of PCSK9 inhibitor therapy with alirocumab: a subanalysis of the ODYSSEY APPRISE studyFrontiers in cardiovascular medicine, 2023-06, Vol.10, p.1206551-1206551 [Peer Reviewed Journal]2023 Banach, Lewek, Pol, Rabczenko, Balanescu, Blaha, Ceska, Jankowski, Surma, Kolovou, Liberopoulos, Mitu, Mitu, Naji, Paragh, Popławska, Vrablik and Pella. ;2023 Banach, Lewek, Pol, Rabczenko, Balanescu, Blaha, Ceska, Jankowski, Surma, Kolovou, Liberopoulos, Mitu, Mitu, Naji, Paragh, Popławska, Vrablik and Pella. 2023 Banach, Lewek, Pol, Rabczenko, Balanescu, Blaha, Ceska, Jankowski, Surma, Kolovou, Liberopoulos, Mitu, Mitu, Naji, Paragh, Popławska, Vrablik and Pella ;ISSN: 2297-055X ;EISSN: 2297-055X ;DOI: 10.3389/fcvm.2023.1206551 ;PMID: 37404744Full text available |
|
16 |
Material Type: Article
|
The Impact of Rapid Weight Loss on Oxidative Stress Markers and the Expression of the Metabolic Syndrome in Obese IndividualsJournal of Obesity, 2013-01, Vol.2013, p.729515-10 [Peer Reviewed Journal]Copyright © 2013 Eva Tumova et al. ;COPYRIGHT 2014 Hindawi Limited ;Copyright © 2013 Eva Tumova et al. 2013 ;ISSN: 2090-0708 ;EISSN: 2090-0716 ;DOI: 10.1155/2013/729515 ;PMID: 24455214Full text available |
|
17 |
Material Type: Article
|
Low LDL-C goal attainment in patients at very high cardiovascular risk due to lacking observance of the guidelines on dyslipidaemiasPloS one, 2023-05, Vol.18 (5), p.e0272883-e0272883 [Peer Reviewed Journal]Copyright: © 2023 Vrablík et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ;COPYRIGHT 2023 Public Library of Science ;2023 Vrablík et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 Vrablík et al 2023 Vrablík et al ;2023 Vrablík et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0272883 ;PMID: 37216363Full text available |
|
18 |
Material Type: Article
|
Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert PanelNutrition reviews, 2017-09, Vol.75 (9), p.731-767 [Peer Reviewed Journal]The Author(s) 2017. Published by Oxford University Press on behalf of the International Life Sciences Institute. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com. 2017 ;The Author(s) 2017. Published by Oxford University Press on behalf of the International Life Sciences Institute. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com. ;ISSN: 0029-6643 ;EISSN: 1753-4887 ;DOI: 10.1093/nutrit/nux047 ;PMID: 28938795Full text available |
|
19 |
Material Type: Article
|
Atherosclerosis - so well-known and still mysteriousPhysiological research, 2017-01, Vol.66, p.I [Peer Reviewed Journal]Copyright Institute of Physiology 2017 ;ISSN: 0862-8408 ;EISSN: 1802-9973Full text available |
|
20 |
Material Type: Article
|
Reporting LDL cholesterol results by clinical biochemistry laboratories in Czechia and Slovakia to improve the detection rate of familial hypercholesterolemiaBiochemia Medica, 2023-10, Vol.33 (3), p.334-341 [Peer Reviewed Journal]Croatian Society of Medical Biochemistry and Laboratory Medicine. 2023 Croatian Society of Medical Biochemistry ;ISSN: 1330-0962 ;EISSN: 1846-7482 ;DOI: 10.11613/BM.2023.030705Full text available |